SCHEMBL18435533

SCHEMBL18435533

CCN[C@@H](Cc1ccccc1)C(=O)NCCO

nearest known ligand 0.64

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.64
▸ TSHR P16473 1/20 0.64
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ BCHE P06276 1/20 0.52
▸ POLB P06746 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ CTSS P25774 4/20 0.48
▸ CTSK P43235 2/20 0.48
▸ SIGMAR1 Q99720 1/20 0.46
▸ CTSL P07711 4/20 0.46
▸ CTSB P07858 2/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ANPEP P15144 1/20 0.46
▸ CHRNB2 P17787 1/20 0.46
▸ CHRNB4 P30926 1/20 0.46
▸ CHRNA3 P32297 1/20 0.46
▸ CHRNA4 P43681 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18435163 0.88 CTSS (0.52) L3MBTL1BCHEPOLBLMNACTSS
SCHEMBL22175312 0.85 CYP3A4 (0.68) CYP3A4TSHRL3MBTL1BCHECTSS
SCHEMBL24476234 0.82 CTSS (0.51) L3MBTL1BCHEPOLBLMNACTSS
SCHEMBL27334440 0.82 CTSS (0.51) L3MBTL1BCHEPOLBLMNACTSS
SCHEMBL25327975 0.82 CYP3A4 (0.63) CYP3A4TSHRL3MBTL1CTSSCTSK
SCHEMBL22025427 0.80 KMT2A (0.59) POLBCTSSCTSKSIGMAR1KMT2A
SCHEMBL25034734 0.80 POLB (0.50) CYP3A4TSHRL3MBTL1BCHEPOLB
SCHEMBL22175193 0.79 CYP3A4 (0.60) CYP3A4TSHRL3MBTL1CTSSCTSK
SCHEMBL7271174 0.79 SIGMAR1 (0.56) L3MBTL1LMNASIGMAR1
SCHEMBL839840 0.79 SIGMAR1 (0.56) L3MBTL1LMNASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861581-B1 1,2,3,4-Tetrahydroisoquinoline-pyrrolidine derivatives as antagonists of apoptosis (IAPs) for the treatment of cancer. BRISTOL MYERS SQUIBB CO (US) 2017-02-01 — — EP disclosed
Send feedback